• MSR49 Non-Systematic Literature Reviews: Can AI Enhance Current Methods?

    Dec 1, 2023, 00:00

  • EE572 Budget Impact Analysis of the Introduction of Endo Arteriovenous Fistula System (WAVELINQ) for Hemodialysis Access Creation in Patients with End-Stage Kidney Disease

    Dec 1, 2023, 00:00

  • HSD71 Management of Care for Patients With Actinic Keratosis in Fran Reakt Study

    Dec 1, 2023, 00:00

  • HPR180 Evaluating the Success of the National Bundle Payment Program for Osteoarthritis

    Dec 1, 2023, 00:00

  • HTA360 A Comparative Assessment of Systematic Literature Review Requirements for Health Technology Assessment, Globally

    Dec 1, 2023, 00:00

  • EPH127 School Environment and Mental Health State in Brazilian Adolescents – Evaluating Public Policy Opportunities

    Dec 1, 2023, 00:00

  • HTA60 Where Can International HTA Collaboration Add Value? the Experience of NICE

    Dec 1, 2023, 00:00

  • P15 Unraveling Acceptance of Healthcare Innovations in Neurorehabilitation: A Systematic Approach Through Health Preference Research

    Dec 1, 2023, 00:00

  • HSD70 Economic Benefit of Empowering Community Pharmacists in the Diagnosis and Treatment of Acute Sore Throat in England

    Dec 1, 2023, 00:00

  • PCR157 Assessment of Health State Utilities for Invasive Pneumococcal Disease, Pneumonia, and Acute Otitis Media in Young Children

    Dec 1, 2023, 00:00

  • EE502 Budget Impact Analysis of Transanal Irrigation for the Treatment of Low Anterior Resection Syndrome in Spain

    Dec 1, 2023, 00:00

  • OP25 Developments in Anticancer Drugs Preparation Activity in Hospitals Pharmacies Units (HPU) and Their Impact on the Activity of Paris University Hospitals (AP-HP)

    Dec 1, 2023, 00:00

  • MSR154 Qualitative Content Analysis for Concept Elicitation (CACE) in Clinical Outcome Assessment Development

    Dec 1, 2023, 00:00

  • EE379 Economic Evaluation of Nubeqal for the Treatment of Adult Patients With Non-Metastatic Castration Resistant Prostate Cancer in the Mexican Context

    Dec 1, 2023, 00:00

  • SA2 A Meta-Regression Tool: Assessing the Relationship Between Risk Factors and Events Development

    Dec 1, 2023, 00:00

  • PCR145 Dupilumab Reduces Systemic Corticosteroid Use in Children with Uncontrolled Moderate-to-Severe Asthma Regardless of Prior Exacerbation History

    Dec 1, 2023, 00:00

  • EE7 Optimizing Aortic Stenosis Management: Evaluating the Clinical and Economic Impact of Transcatheter and Surgical Valve Replacement in Taiwan

    Dec 1, 2023, 00:00

  • HPR196 Loss of Exclusivity (LOE): Impact Analysis across Europe-5 and Select Nordic Countries

    Dec 1, 2023, 00:00

  • RWD98 Health Care Resource Use and Costs of Hemophilia A in France

    Dec 1, 2023, 00:00

  • HPR31 Is the UK’S Ilap Process Delivering Its Intended Benefits? a Review of Access to Orbis Designated Oncology Products within the UK

    Dec 1, 2023, 00:00

  • EE9 Cost-Effectiveness of Icosapent Ethyl for Patients at High Cardiovascular Risk with Elevated Triglycerides in Greece

    Dec 1, 2023, 00:00

  • EE587 A Systematic Scoping Review to Identify Challenges in the Economic Evaluation of Prognostic and Predictive Companion Diagnostics in Personalized Medicine: The Radioval Study

    Dec 1, 2023, 00:00

  • EE432 Propel® Technology – A Budget Impact Analysis in the Italian Context

    Dec 1, 2023, 00:00

  • PCR35 Health-Related Quality of Life and Its Drivers for Patients Living With Cystic Fibrosis in Five Key European Countries: A Systematic Review

    Dec 1, 2023, 00:00

  • EE303 Cost-Utility Analysis of Roflumilast Cream for Plaque Psoriasis, Including Intertriginous, From the Canadian Societal Perspective

    Dec 1, 2023, 00:00

  • EE159 Cost-Effectiveness Analysis of an Adjusted Polygenic Risk Score in Cardiovascular Disease Prevention

    Dec 1, 2023, 00:00

  • EE449 Uncertainty Around HRQoL Values Is Under-Reported: Are We Misleading Decision Makers?

    Dec 1, 2023, 00:00

  • SA30 A Systematic Review of the Use of Registry-Based Randomized Controlled Trials (R-RCTs) for Regulatory Approval and Access

    Dec 1, 2023, 00:00

  • EPH226 Estimating the Future Prevalence, Costs, and Clinical Impact of Overweight and Obesity Classes I, II, and III in the UK

    Dec 1, 2023, 00:00

  • EE102 Economic Burden of Short-Acting Beta-2 Agonist Overuse Among Asthma Patients in Turkiye: A Cost Analysis with Respect to Updated Recommendations of the Global Initiative for Asthma

    Dec 1, 2023, 00:00

  • HTA171 The Use of Qualitative Methods in the NICE HST Deliberative Process

    Dec 1, 2023, 00:00

  • HPR221 A Reconstruction and Validation of the Rationale Underlying the Ec Proposal to Make Regulatory Data Protection (RDP) Conditional upon Supply in EU Member States

    Dec 1, 2023, 00:00

  • MSR89 Criteria and Methods Applied to Decision-Making to Embark on Late-Stage Clinical Trials With a Multi-Stakeholder Perspective

    Dec 1, 2023, 00:00

  • EE653 A Health Economic Model to Assess the Effects of Introducing Home Polysomnography for the Diagnosis of Sleep Apnea in Germany

    Dec 1, 2023, 00:00

  • EE562 What Is More Valuable Than Optimal Resource Use? The Development of Interactive Tool Visualizing the Costs and Time Consumption Related to Diabetic Macular Edema’s Intravitreal Treatments in Finland

    Dec 1, 2023, 00:00

  • PCR198 Should We be Mapping from Sleep-Specific to Generic Preference-Based Quality-of-Life Instruments? Unravelling the Debate with a Multi-Instrument Mapping Study of 6 Sleep-Specific and 4 Preference-Based Instruments

    Dec 1, 2023, 00:00

  • MSR135 Do You Really Need to See the Doctor? Developing a Machine Learning Approach for Optimal Assignment Rules of Physician Visits for Patients After Knee Replacement

    Dec 1, 2023, 00:00

  • HTA163 Setting Treatment Selection Criteria for Breast Cancer From a Clinician Perspective: Is It a Matter of Cost?

    Dec 1, 2023, 00:00

  • HSD38 From Unpersonalized to Personalized Breast Follow-up in Clinical Practice in the Netherlands: Will Artificial Intelligence Make a Difference?

    Dec 1, 2023, 00:00

  • RWD133 Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany

    Dec 1, 2023, 00:00

  • HTA124 Can You Have a Common Approach to the Statistical Analysis Plan When Conducting Real-World Evidence Studies to Meet Multi-HTA Requirements?

    Dec 1, 2023, 00:00

  • SA78 Active Participation of Children in Health Research: Methods, Experience and Ethical Aspects

    Dec 1, 2023, 00:00

  • MT61 Differences and Similarities of Health Economic Evaluation for Medical Technologies By HTA Bodies

    Dec 1, 2023, 00:00

  • RWD14 Endometrial Cancer First Line Treatment in Argentina: ECHOS-A Real-World Study

    Dec 1, 2023, 00:00

  • EE455 Cost Saving Potential of Rapid Microbiological Methods: Case Form Bulgaria

    Dec 1, 2023, 00:00

  • EE359 Cost-Effectiveness of Pembrolizumab + Chemotherapy Versus Cetuximab-Containing Regimens ‘Extreme’ and ‘TPEx’, for R/M SCCHN Patients with a CPS between 1 and 19, in Italy

    Dec 1, 2023, 00:00

  • MT6 Companion Diagnostics’ Launch and Market Access Landscape: Who Are the Trend Setters and Late Adopters?

    Dec 1, 2023, 00:00

  • EE19 Cost Utility Analysis of the Flash Glucose Monitoring System in the Management of People With Type 2 Diabetes Mellitus on Basal Insulin Therapy—An Italian Healthcare System Perspective

    Dec 1, 2023, 00:00

  • SA37 A Real-World Evaluation of People with Drug-Resistant Focal Epilepsy Across Six European Countries

    Dec 1, 2023, 00:00

  • MSR80 AI-Enabled Risk of Bias Assessment of RCTs in Systematic Reviews: A Case Study

    Dec 1, 2023, 00:00

  • CO184 Exploring the Relationship Between Surrogate and Long-Term Outcomes in Lysosomal Storage Diseases: A Targeted Literature Review

    Dec 1, 2023, 00:00

  • HSD131 Long-Term Impact of a Comprehensive Care Coordination Program on Medicaid Expenditures Among Children and Young Adults with Chronic Diseases

    Dec 1, 2023, 00:00

  • PT45 Disease Relapse and Adverse Events During the Combination Use of Clozapine and Long-Acting Injectable Antipsychotics and During the Clozapine Monotherapy

    Dec 1, 2023, 00:00

  • EE147 "I'll Live Less, You'll Live Better, Let's Make It Count": A Qualitative Exploration of Drivers Barriers for Sacrificing Remaining Life Expectancy to Restore Relatives to Full Health in Time Trade Off Exercises

    Dec 1, 2023, 00:00

  • PCR271 Employing Episodic Future Thinking to Reduce the Distortion of Time Preference in Time Trade-Off Valuation

    Dec 1, 2023, 00:00

  • PCR66 Psychometric Validation of PROMIS-Fatigue-MS-8a Questionnaire in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab

    Dec 1, 2023, 00:00

  • EE47 Cost of Illness Study of Migraine in Bulgarian Patients

    Dec 1, 2023, 00:00

  • SA58 Approaches to Examine Treatment Adherence and Persistence Using German Claims Data: An Exemplary Analysis Using Oral Therapies for Prostate Cancer

    Dec 1, 2023, 00:00

  • EE113 The Use of Ferric Carboxymaltose for Pregnant and Postpartum Women in Brazil: Estimation of Target Poputation and Budget Impact Analysis from the Public Health Care System Perspective

    Dec 1, 2023, 00:00

  • P3 Open-Source Model Framework for Health-Economic Evaluation of Early Treatment in Alzheimer's Disease

    Dec 1, 2023, 00:00

  • EPH124 Validity of Outpatient ICD-10 Codes to Identify Respiratory Syncytial Virus (RSV) – Estimating Sensitivity and Specificity of Health Administrative Claims Data

    Dec 1, 2023, 00:00

  • P18 Adjusted Comparison of Teclistamab Versus Real-World Physician’s Choice (RWPC) of Therapy in Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • HTA245 UK Mechanisms to Address Rare Disease Challenges: Does the UK Go Far Enough?

    Dec 1, 2023, 00:00

  • EPH159 Evaluation of Invasive Pneumococcal Disease and Pneumococcal Vaccination Coverage in a Hospital of Spain

    Dec 1, 2023, 00:00

  • EE181 COVID-19 Related Work Absenteeism and Its Associated Lost Productivity Cost in Germany: A Population-Based Study

    Dec 1, 2023, 00:00

  • PT22 Exploring Reimbursement Disparities: A Comparative Study of Pharmaceutical Access in Hong Kong and Mainland China

    Dec 1, 2023, 00:00

  • HPR103 Potential Impacts of the EMA-HMA Join Statement Supporting Biosimilar Interchangeability in Biosimilar Access in the EU

    Dec 1, 2023, 00:00

  • HTA131 Cost-Effectiveness Threshold in Denmark's New Health Technology Assessment Process: What Do We Know so Far?

    Dec 1, 2023, 00:00

  • MT63 Value Assessment of Combination Digital Health Technologies Under New NICE Evidence Standards Framework: Evidence Submitted and Key Factors for Positive Recommendation

    Dec 1, 2023, 00:00

  • EE626 Budget Impact Analysis (BIA) of Adopting Real-Time Continuous Glucose Monitoring (rt-CGM) vs Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients With Type 1 Diabetes on Insulin Therapy (PWT1D) in Italy

    Dec 1, 2023, 00:00

  • PCR230 Real-World Clinical Characteristics of Patients with Migraine Who Initiated Fremanezumab in Sweden: An Observational, Nationwide Register-Based Study

    Dec 1, 2023, 00:00

  • HTA224 Improving Access to Behavioral and Mental Health Therapies in the EU: An Analogue Assessment Deep Dive

    Dec 1, 2023, 00:00

  • MSR2 Development of an Algorithm to Identify the Type of Diabetes in the French Administrative Health Care Database “Système National Des Données De Santé” (SNDS)

    Dec 1, 2023, 00:00

  • HPR37 Squaring the Circle? Leveraging Early Access / Compassionate Use Pathways to Provide Market-Specific Real-World Evidence Before Launch

    Dec 1, 2023, 00:00

  • HPR85 Opinions on Sustainable Healthcare Financing Options for Funding New Medical Technologies in ASEAN-6

    Dec 1, 2023, 00:00

  • EE568 Does the Introduction of an Infliximab Biosimilar Always Result in Savings for Hospitals? A Descriptive Study Using Real-World Data

    Dec 1, 2023, 00:00

  • PCR122 Psychometric Evaluation of Multiple Sclerosis Impact Scale 29 Version 2 in Relapsing Multiple Sclerosis Patients Participating in a Phase 2 Study of Frexalimab

    Dec 1, 2023, 00:00

  • PCR214 Patient Voice in Pharmaceutical Company: The Case of Patient Committee in Brazil

    Dec 1, 2023, 00:00

  • CO178 Understanding Physicians’ Decision-Making Practices Related to Biomarker Testing: Analysis of the Adelphi Real-World Ovarian Cancer II Disease Specific Programme (DSPTM)

    Dec 1, 2023, 00:00

  • HPR124 Opportunities for Improving Healthcare for Migrant Populations, as Identified by Healthcare Teams in Various Regions of Chile

    Dec 1, 2023, 00:00

  • MSR161 Quantifying the Impact of Exposure Prevalence and Selection Bias to Optimize Patient Selection Criteria in Post-Authorization Safety Studies

    Dec 1, 2023, 00:00

  • MT37 Clinical Utility of Circulating Tumor Cell (CTC) Enumeration-Based Liquid Biopsy and HER2 CTC Assessment in Patients with Metastatic Breast Cancer: Overview of Current Available Data and Interventional Trials

    Dec 1, 2023, 00:00

  • EE639 Explorative Cost-Effectiveness Analysis of a Rapid ID/AST Solution for Patients with Bloodstream Infection

    Dec 1, 2023, 00:00

  • EE424 Cost-Utility and Budget Impact Analyses of Tumor Necrosis Factor Inhibitor Biologics and Biosimilars Versus Rituximab in Thai Patients with Active Rheumatoid Arthritis

    Dec 1, 2023, 00:00

  • MSR103 Translation, Cultural Adaptation, and Psychometric Testing of the Hip Disability and Osteoarthritis Outcome Score Into Yoruba Language

    Dec 1, 2023, 00:00

  • EPH190 Clinical Characteristics and Treatment Patterns of Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Mexico

    Dec 1, 2023, 00:00

  • HPR157 Challenges and Potential Solutions in Implementing a Bundle Payment Program for Osteoarthritis

    Dec 1, 2023, 00:00

  • MT70 Robotic-Assisted Surgery Versus Open Surgery in Endometrial Cancer: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • CO88 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis

    Dec 1, 2023, 00:00

  • RWD108 Real-World Data and Real-World Evidence Terminology Harmonization: Evidence Gaps and Future Steps

    Dec 1, 2023, 00:00

  • OP27 Observations of Patient Preference in the Creation of Treatment Support Materials

    Dec 1, 2023, 00:00

  • EE469 Diabetic Retinopathy in Algeria: Costs Estimation and Medical-Economic Value of Automated Methods AI-Based in Early Screening

    Dec 1, 2023, 00:00

  • EE120 Cost-Effectiveness of Difelikefalin for the Treatment of Moderate to Severe Chronic Kidney Disease-Associated Pruritus (CKD-AP) in Adult Patients Receiving in-Centre Haemodialysis

    Dec 1, 2023, 00:00

  • HSD123 Environmental Impact of Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in the Netherlands

    Dec 1, 2023, 00:00

  • PCR84 The Daily Life and Psychosocial Impacts of Friedreich Ataxia: A Qualitative Study of Patient Lived Experiences

    Dec 1, 2023, 00:00

  • PT48 International Reference Pricing Analysis of Medicines in Turkiye By 2022

    Dec 1, 2023, 00:00

  • EE18 Economic Burden of Type 2 Diabetes in Peru: A Cost-of-Illness Study Valuing Cost Differences Associated With the Level of Glycemic Control

    Dec 1, 2023, 00:00

  • RWD44 Utilization of Short-Term and Long-Term Disability, and Workers' Compensation in Employees with Major Depressive Disorder Compared with Employed Controls

    Dec 1, 2023, 00:00

  • EE302 Value of End-of-Life Health Gains

    Dec 1, 2023, 00:00

  • PCR176 Establishing the Interchangeability Between CSF and PET to Identify Patients With Alzheimer's Disease Pathology

    Dec 1, 2023, 00:00

  • EE667 Cost-Minimization Analysis (CMA) of Bruton Tyrosine Kinase Inhibitors (BTKi) in Adults with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

    Dec 1, 2023, 00:00

  • EE128 Budget Impact of the Jada System for the Treatment of Patients with Abnormal Post-Partum Bleeding or Hemorrhage in the United States

    Dec 1, 2023, 00:00

  • EE614 Evaluating the Cost-Effectiveness of CYP2C19 Genetic Testing in Patients Who Have Experienced an Ischaemic Stroke or Transient Ischaemic Attack in England and Wales

    Dec 1, 2023, 00:00

  • HTA35 G-BA Vs. InEK: Navigating Divergent Requirements Between the Two Key Bodies Behind Inpatient Drug Reimbursement in Germany

    Dec 1, 2023, 00:00

  • OP14 Analysis of Interregional Variability in the Market Penetration of Immuno-Oncological Drugs in Italy

    Dec 1, 2023, 00:00

  • RWD173 Chronification in the Use of Benzodiacepines: Incidence Stratified by Sex and Age Groups

    Dec 1, 2023, 00:00

  • EE72 A Cost-Effectiveness Analysis of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-Small Cell Lung Cancer in Portugal

    Dec 1, 2023, 00:00

  • MSR102 Advancing Causal Inference With Machine Learning and Real-World Data: An Application of Targeted Machine Learning and Super Learners on Hospital-Acquired Pressure Injuries From MIMIC IV

    Dec 1, 2023, 00:00

  • MT56 Beyond the Hype - Economic Evaluation and Artificial Intelligence Maturity Level in Healthcare

    Dec 1, 2023, 00:00

  • EE649 Cost Per Responder of Bimekizumab Against Il-17A, IL-12/23 and IL-23 Inhibitors in the Treatment of Psoriatic Arthritis in Sweden

    Dec 1, 2023, 00:00

  • EE646 Waiting Times and Cost-Effectiveness: An Early Case Study in Cognitive Behavioral Therapy for Anxiety

    Dec 1, 2023, 00:00

  • EE64 Change in Healthcare Resource Use and Associated Costs of Patients with Metastatic Lung Cancer between 2013 and 2019: An Observational Study from the French National Claims Database

    Dec 1, 2023, 00:00

  • HTA333 A Systematic Review of Robotic-Assisted Surgery in Esophageal Cancer: Comparison with Open Esophagectomy

    Dec 1, 2023, 00:00

  • HTA141 Exploring the Role of Patient Experience Data and Patient Involvement in Health Technology Assessment Decision Making

    Dec 1, 2023, 00:00

  • HPR97 Healthcare Systems Resilience and the COVID-19 Emergency: How Care Can Be Improved Within the Current Budget and Resources Constraint by Increasing the Efficiency of Healthcare Delivery

    Dec 1, 2023, 00:00

  • HTA8 Health Technology Assessment (HTA) Case Studies: Comparing Acceptability of Real-World Evidence (RWE) in Appraisals for Oncology Medicines

    Dec 1, 2023, 00:00

  • HPR174 Effects of Having a Usual Source of Care with Physician on Medical Expenses in Korea

    Dec 1, 2023, 00:00

  • EE192 The Cost-Effectiveness of a Bimekizumab Versus Secukinumab Treatment Pathway in Patients with Active Axial Spondyloarthritis in Scotland

    Dec 1, 2023, 00:00

  • EE335 Burden of COVID-19 Related Hospitalization in Adults at High Risk for Severe Disease Progression in Germany—A Retrospective Claims Data Analysis

    Dec 1, 2023, 00:00

  • HPR135 The Need for Novel Mechanisms to Tackle the Global Antimicrobial Resistance (AMR) Threat: Are Innovative Payment Models Enough?

    Dec 1, 2023, 00:00

  • HSD96 Trends in the Therapeutic Management of Bullous Pemphigoid in the Real-World Setting

    Dec 1, 2023, 00:00

  • HPR73 Underfunding of Public Health System and Unmet Dental Needs Among the European Elderly Population

    Dec 1, 2023, 00:00

  • PT27 How Much Does TLV Value Rarity? A Review of Reimbursement Decisions on Orphan Drugs in Sweden from 2017 through 2022

    Dec 1, 2023, 00:00

  • EE480 Cost-Effectiveness Analysis of an Implantable Device for Chronic Gastro-Oesophageal Reflux Disease in Sweden

    Dec 1, 2023, 00:00

  • SA40 Patient-Level Simulation Models in Cancer Care

    Dec 1, 2023, 00:00

  • EPH51 Artificial Intelligence (AI) Tools for Outbreak Detection and Response: A Transnational Platform for Surveillance, Monitoring and Decision Support

    Dec 1, 2023, 00:00

  • MSR7 Incorporating External Data to Inform Overall Survival Extrapolation: A Review of NICE Health Technology Appraisals for Oncology Drugs

    Dec 1, 2023, 00:00

  • P27 How Untruthfulness in Self-Reported Medication Adherence Influences Treatment Preferences: A Discrete Choice Experiment

    Dec 1, 2023, 00:00

  • SA75 The Use of Formal Expert Opinion Elicitation to Inform Model Structure and Inputs in Rare Diseases

    Dec 1, 2023, 00:00

  • EE691 Economic Evaluation and Budget Impact of RVd as Induction Regimen Prior to ASCT in Patients with Newly Diagnosed Multiple Myeloma from the Perspective of the Public Health Sector in Mexico

    Dec 1, 2023, 00:00

  • EPH143 Health Behavior and Quality of Life in Women With Endometriosis

    Dec 1, 2023, 00:00

  • EPH225 The Shifting Patterns of Childhood Obesity: Insights from Population-Based Data

    Dec 1, 2023, 00:00

  • EE91 A Systematic Literature Review of Health-Related Quality of Life, Costs, and Healthcare Resource Use in Primary Biliary Cholangitis

    Dec 1, 2023, 00:00

  • PCR50 The Adelphi Adherence Questionnaire (ADAQ©): Psychometric Validation of a New Patient Self-Report Measure of Medication Adherence Across Multiple Disease Areas

    Dec 1, 2023, 00:00

  • PCR107 (How) Should Cost-Effectiveness Analysis Accommodate Heterogeneity in Patient Preferences?

    Dec 1, 2023, 00:00

  • EPH79 Epidemiology of Systemic Mastocytosis (SM) and Indolent Systemic Mastocytosis (ISM) in Germany

    Dec 1, 2023, 00:00

  • HTA229 PICO Criteria Applied in Joint Action 3 Differ From National HTA Requirements: A Review of Oncology Drug Assessments in Denmark, France, Germany, and Sweden

    Dec 1, 2023, 00:00

  • HTA265 Development of the Reliant Checklist to Support the HTA Deliberation

    Dec 1, 2023, 00:00

  • HTA304 The Impact of Different HTA Frameworks on Time to Patient Access: A Case Study Assessing the First Commercial Launch Indications for Lynparza, Tagrisso, Imfinzi, Calquence and Enhertu

    Dec 1, 2023, 00:00

  • CO95 Matching-Adjusted Indirect Comparison (MAIC) in Previously Treated KRAS G12C-Mutated Advanced/Metastatic Non-Small Cell Lung Cancer (a/mNSCLC): Adagrasib Versus Sotorasib

    Dec 1, 2023, 00:00

  • EPH239 Incremental Cost Burden of Major Depressive Disorder in Patients with Rheumatoid Arthritis in Korea

    Dec 1, 2023, 00:00

  • HPR101 Maximizing the Quality of Comparative Evidence in Externally Controlled Studies—The Need for a Unified Framework

    Dec 1, 2023, 00:00

  • MSR148 Methodological Aspects of Composite Measures: A Comparison of Techniques for Rescaling and Aggregation

    Dec 1, 2023, 00:00

  • EE530 Global Clinical, Economic, Health-Related Quality of Life Burden, and Treatment Outcomes in Follicular Lymphoma: A Systematic Review

    Dec 1, 2023, 00:00

  • EE112 Economic Burden of SLE in Nordic Countries - a Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • EPH264 The Potential Public Health Impact of the Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine Among Adults Aged 60 and Older in Italy: Preliminary Results of a Markov Model Analysis

    Dec 1, 2023, 00:00

  • EPH166 Access Trends to Cardiac Implantable Electronic Devices in the Brazilian Public Healthcare System: A Twelve-Year Real World Data Analysis

    Dec 1, 2023, 00:00

  • EPH77 An Incidence- and Survival-Based Epidemiological Model for the Prevalence of Duchenne Muscular Dystrophy in Nine Countries

    Dec 1, 2023, 00:00

  • EE567 Economic Evaluations of Pharmacological Interventions for Lupus Population – a Targeted Literature Review

    Dec 1, 2023, 00:00

  • OP18 Are We Ready for a Digital Transformation in HEOR and Market Access?

    Dec 1, 2023, 00:00

  • EE29 Clinical and Economic Impact of Pre-Exposure Prophylaxis With Tixagevimab+Cilgavimab in 2022 in Switzerland to Protect Immunocompromised Individuals

    Dec 1, 2023, 00:00

  • PCR123 Assessing the Impact of Relapses on Burden to the Patient and Caregiver in NMOSD

    Dec 1, 2023, 00:00

  • HPR106 New Proposed European Commission Pharmaceutical Regulation – Potential Changes and Impact on Manufacturers With a Focus on Eastern Southern European Member States

    Dec 1, 2023, 00:00

  • PCR234 The Burden of Migraine in Czech Republic: Patient, Payer, and Societal Perspective

    Dec 1, 2023, 00:00

  • RWD83 Epidemiological Characterization of the Current Patient Population of Multiple Sclerosis Patients Enrolled in a Patient Registry for Interferon-Beta 1a SC in Portugal

    Dec 1, 2023, 00:00

  • EE637 Economic Impact of Managing Invasive Mold Disease With Isavuconazole Compared With Liposomal Amphotericin B in Spain

    Dec 1, 2023, 00:00

  • PCR5 First Interim Analysis of Patient-Reported Outcomes in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study of Vonoprazan in Real-World Clinical Practice in China

    Dec 1, 2023, 00:00

  • MT65 Systematic Review of the Health-Economic Impact of Diagnostic Modality Selection for Patients with Coronary Artery Disease

    Dec 1, 2023, 00:00

  • EE643 Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 PCR Screening: A Cost-Utility Analysis

    Dec 1, 2023, 00:00

  • RWD79 Impact of Google Searches on Suicide Rates in Colombia

    Dec 1, 2023, 00:00

  • MT76 DiMe Library of Digital Endpoints: Strengths, Weaknesses, and Pathways for Improvement in Digital Health Research

    Dec 1, 2023, 00:00

  • CO93 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Versus Selinexor-Dexamethasone for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)

    Dec 1, 2023, 00:00

  • EE442 An Economic Evaluation of Universal Childhood Varicella Vaccination in Ireland

    Dec 1, 2023, 00:00

  • EE295 Willingness to Pay for COVID-19 Vaccines in Hungary

    Dec 1, 2023, 00:00

  • EPH115 Primary Prevention Strategies for Stroke: A Multilevel Approach

    Dec 1, 2023, 00:00

  • EE742 The Comparative Healthcare Cost between Robotic Esophagectomy and Video-Assisted Esophagectomy for Esophageal Cancer in Japan

    Dec 1, 2023, 00:00

  • EPH29 Estimating the Incidence and Characteristics of Female Patients in Norway With Early Breast Cancer Who Are at High Risk of Disease Recurrence

    Dec 1, 2023, 00:00

  • HSD46 Multidisciplinary Discussion for Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: A Cross Sectional Survey to Evaluate the Experiences of Multidisciplinary Teams in Italy

    Dec 1, 2023, 00:00

  • CO128 Health-Related Quality of Life in Generalized Myasthenia Gravis- the Relationship between MG-ADL and EQ-5D-5L in the Raise Study

    Dec 1, 2023, 00:00

  • EE496 Botulinum Toxin Type a for the Treatment of Focal Spasticity in Children with Cerebral Palsy in Thailand: A Cost-Utility Analysis

    Dec 1, 2023, 00:00

  • EE28 Cost-Effectiveness Formulation of PCR-Test Screening for COVID-19 Regarding Multiple Factors in Epidemic

    Dec 1, 2023, 00:00

  • EE348 The Economic Burden of Multiple Sclerosis in an Italian Cohort of Patients: Analysis of Disease Cost and Its Components

    Dec 1, 2023, 00:00

  • EE152 The Implicit Devaluation of Health Benefits Over Time in NICE Decision-Making Criteria: Assessing NICE’s Static Willingness to Pay Threshold in the Context of Inflation.

    Dec 1, 2023, 00:00

  • MSR153 Can ChatGPT Generate Synthetic Data to Train Systematic Literature Review Machine Learning Models?

    Dec 1, 2023, 00:00

  • HPR194 New Framework for Early Access to Drugs in Fran Feedback After a One-Year Use in University Public Hospitals of Paris

    Dec 1, 2023, 00:00

  • RWD32 Hearing the Patient Voice in Japan – Utilisation of Patient-Reported Outcomes and Wearable Device Data for Patient-Centric Real-World Research

    Dec 1, 2023, 00:00

  • PCR228 Among European Individuals with Major Depressive Disorder, Higher Severity of Insomnia Symptoms Is Independently Associated with Poorer Health-Related Outcomes

    Dec 1, 2023, 00:00

  • EE320 Impact of NASH Disease Model Adjustment to New Literature Findings: Assessing Cost-Effectiveness of Actual and Theoretical Treatments

    Dec 1, 2023, 00:00

  • PCR151 Health Related Quality of Life (HRQOL) Among Patients with Transthyretin Amyloidosis (ATTR): A Systematic Literature Review

    Dec 1, 2023, 00:00

  • EE524 Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab for High-Risk Early-Stage Triple Negative Breast Cancer in Costa Rica

    Dec 1, 2023, 00:00

  • MSR150 Artificial Intelligence (AI) in Performing Landscape Review and Linguistic Analysis for Curative Intent in Prostate Cancer (PC)

    Dec 1, 2023, 00:00

  • EE582 Actuarial Value Chain Modelling of Valoctocogene Roxaparvovec (VALROX) Therapy for Hemophilia A: An Adaptation from ICER Final Evidence Report*

    Dec 1, 2023, 00:00

  • SA28 Evaluation of Disease Epidemiology, Comorbidities, Treatment Patterns, and Healthcare Resource Utilization of Alopecia Areata in United Arab Emirates: A Retrospective Claims Database Study

    Dec 1, 2023, 00:00

  • PCR30 Benefits and Challenges of Different Qualitative Approaches in Rare Disease: A Case Study in Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) Using a Narrative Exercise and Qualitative Interviews

    Dec 1, 2023, 00:00

  • HPR104 A Review of Biosimilar Utilization across EU4 and UK Since the Introduction of the First Biosimilar

    Dec 1, 2023, 00:00

  • EE533 Healthcare Resource Utilization (HCRU) and Related Direct Healthcare Costs for Patients with Metastatic Urothelial Cancer (mUC): Findings from a Retrospective Observational Cohort Study in a Clinical Practice Setting in Italy

    Dec 1, 2023, 00:00

  • RWD157 Assessment of Real-World Treatment Patterns and Healthcare Resource Utilization (HCRU) in Patients with Lenalidomide-Refractory Relapsed/Refractory Multiple Myeloma (RRMM) from the US Optum Database

    Dec 1, 2023, 00:00

  • EPH171 Clinical, Economic, and Patient-Reported Impact of Obesity in the Asia-Pacific Region: A Systematic Review

    Dec 1, 2023, 00:00

  • EE357 Cost per Responder Analysis Comparing Adagrasib and Sotorasib in Patients With KRAS G12C-Mutated Previously Treated Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2023, 00:00

  • CO75 Non-Pharmacological Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Comprehensive Review

    Dec 1, 2023, 00:00

  • RWD38 Implement a Direct-to-Patient Application to Recruit Diverse Patients and Collect Real-World Data

    Dec 1, 2023, 00:00

  • HTA176 Feasibility of Cervical Cancer Screening Policy Using Self-Collected Samples for HPV DNA Testing in Thailand

    Dec 1, 2023, 00:00

  • EE374 Estimating the Impact of Tumors of the Oesophageal and Gastro-Oesophageal Junction on Work, Leisure and Household Activity Times: Evidence from a Patient Survey in Switzerland

    Dec 1, 2023, 00:00

  • EPH229 Hospitalization Patterns and Costs of Primary Biliary Cholangitis (PBC) in Germany

    Dec 1, 2023, 00:00

  • PCR249 Quality of Life of Moroccan Children with Rare Diseases: Evidence from Real-World Data

    Dec 1, 2023, 00:00

  • EE578 Estimating Economic Impact of Fenofibrate Among Patients with Diabetic Retinopathy in China

    Dec 1, 2023, 00:00

  • RWD131 A Nationwide Feasibility Study and Study Concept to Assess the Burden of Duchenne Muscular Dystrophy (DMD) in Finland

    Dec 1, 2023, 00:00

  • EE257 Real-World, Longitudinal, Retrospective Study of Healthcare Resource Utilization of Patients With Atopic Dermatitis Under the Public Health Insurance Plan of Quebec, Canada

    Dec 1, 2023, 00:00

  • PCR200 Characteristics at Baseline of Patients with Asthma and Prior Systemic Corticosteroid Use Initiating Dupilumab Enrolled in the Real-World Study Rapid

    Dec 1, 2023, 00:00

  • MSR137 Consideration of Competing Risks in Early Setting in Oncology and Impact on the Survival Estimates: To Explicitly Model Them? An Example of a French Real-World Cohort in Urothelial Carcinoma

    Dec 1, 2023, 00:00

  • EE527 The Indirect Costs and Burden of Vaccine Preventable Cancers Mortality in Middle East and North Africa (MENA) Countries

    Dec 1, 2023, 00:00

  • PCR53 To What Extent European Value-Based Pricing Methodologies Take Into Account Patient Perspectives and Broader Societal Benefits?

    Dec 1, 2023, 00:00

  • EPH217 Discriminant Validity of EQ-5D-Y-3L Between Children-Reported Health-Related Quality of Life and Parent-Reported Developmental Disabilities

    Dec 1, 2023, 00:00

  • HTA228 Can Just Three PICOs be Feasible for Oncology Assessments with the Joint EU HTA Framework, Whilst Considering All 27 Member States Specificities?

    Dec 1, 2023, 00:00

  • HPR192 Does Including Biosimilars Earlier in the Treatment Pathways Lead to Cost Savings in Rheumatology?

    Dec 1, 2023, 00:00

  • EE698 A Systematic Literature Review of Economic Evaluations in Primary Biliary Cholangitis

    Dec 1, 2023, 00:00

  • CO98 Health Outcomes and Cost-Effectiveness of Atezolizumab in Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EE657 Health Resource Utilization by Disease Stage for People with Amyotrophic Lateral Sclerosis (pALS) in the French National Health Data System (SNDS)

    Dec 1, 2023, 00:00

  • EE23 Cost Utility Analysis of Once-Weekly Semaglutide and Dulaglutide for Patients With Type 2 Diabetes in Saudi Arabia

    Dec 1, 2023, 00:00

  • EPH102 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) Among Canadian Infants

    Dec 1, 2023, 00:00

  • EPH165 Assessing Public Health Models in Fran A Systematic Review

    Dec 1, 2023, 00:00

  • EE457 Cost-Effectiveness Analysis of Patiromer in Heart Failure Patients with Reduced Ejection Fraction for the Treatment of Hyperkalemia: Analysis of the Diamond Clinical Trial

    Dec 1, 2023, 00:00

  • SA51 Definition and Methodology of Rapid Literature Reviews

    Dec 1, 2023, 00:00

  • RWD148 Using Linked Data: Agreement in Diagnosis for Patients with Asthma or Diabetes

    Dec 1, 2023, 00:00

  • RWD35 Health Status Changes of Refugees from North Korea After Defection: Using National-Wide Big Data in South Korea

    Dec 1, 2023, 00:00

  • HPR161 HTA and Economic Evaluations for a Genomic Strategy in Italy

    Dec 1, 2023, 00:00

  • PCR171 Translation and Cross-Cultural Validation of the Chinese Version of Adult Social Care Outcomes Toolkit for Service Users in Hong Kong

    Dec 1, 2023, 00:00

  • EE554 Cost-Effectiveness Analysis of Novoseven® Treatment for Postpartum Hemorrhage in Turkiye

    Dec 1, 2023, 00:00

  • EE658 Cost-Consequence of Cladribine Tablets for the Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis (RRMS) in the UK

    Dec 1, 2023, 00:00

  • EE525 Cost Effectiveness of the Chimeric Antigen Receptor (CAR) T Cell Treatment Lisocabtagene Maraleucel (Liso-Cel) As Second-Line (2L) Treatment of Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) in Switzerland

    Dec 1, 2023, 00:00

  • EE115 Cost-Effectiveness Analysis of Using Ketoanalogues of Essential Aminoacids in Patients With Chronic Kidney Disease in Kazakhstan

    Dec 1, 2023, 00:00

  • MSR91 What Are Unmet Needs for the Use of Registries in Regulatory/HTA Decision-Making in Europe? A Survey-Based Approach From the More-EUROPA Project

    Dec 1, 2023, 00:00

  • HSD101 Development of an Adjusted Outpatient Surgery Index (AOSI) Using Machine Learning Methods

    Dec 1, 2023, 00:00

  • HTA144 NICE Value Male Lives More Than Female Lives?

    Dec 1, 2023, 00:00

  • RWD25 Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada

    Dec 1, 2023, 00:00

  • HSD119 Patient Pathways, Genetic Testing, and Diagnosis of X-Linked Retinitis Pigmentosa in Europe: Insights from the Cross-Sectional Explore Xlrp-1.2 Physician Survey

    Dec 1, 2023, 00:00

  • HPR59 Evolving Global Regulatory Landscape for Approval of Biosimilars: A Structured Literature Review on Current Challenges and Future Considerations

    Dec 1, 2023, 00:00

  • HTA89 An Increased Use of External Data to Inform Survival Extrapolations in NICE Technology Appraisals

    Dec 1, 2023, 00:00

  • CO170 Treatment Exposure-Adjusted Event Rates (EAERs) for Grade 3/4 AEs Associated with Emerging and Existing Systemic Therapies for mCRC with at Least 2 Prior Lines of Therapy: Informing Payer and Pathway Formulary Decision Making

    Dec 1, 2023, 00:00

  • RWD168 Epidemiology of Respiratory Syncytial Virus in Uppsala and Stockholm: A Population-Based Study

    Dec 1, 2023, 00:00

  • HPR198 By Any Genes Necessary: Review of Pipeline Developments and Access Hurdles Likely to be Faced By Gene Therapies

    Dec 1, 2023, 00:00

  • MSR144 The Impact of Enhanced Access to Modern Antineoplastic Drugs for Breast Cancer Treatment on Mortality and Economic Development

    Dec 1, 2023, 00:00

  • EE176 Hospitalization Trends for All Intestinal Infectious Diseases Since Introduction of Rotavirus Gastroenteritis (RVGE) Vaccine in Ireland

    Dec 1, 2023, 00:00

  • EE360 Clinical and Economic Evaluation of Atezolizumab Versus Durvalumab Administration in Adult Patients with Extensive Stage Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • HTA275 Trends in Medical Services Reimbursement Outcomes in Australia: A Novel and Comprehensive Analysis

    Dec 1, 2023, 00:00

  • PCR57 A Qualitative Interview Study to Evaluate Single-Tablet Combination Therapy (STCT) Within a Phase 3 Pulmonary Arterial Hypertension (PAH) Clinical Trial – Interim Analysis

    Dec 1, 2023, 00:00

  • PCR169 Prevalence and Predictive Factors of Psychological Distress Among People with Diabetes in France

    Dec 1, 2023, 00:00

  • MSR10 Incidence, Prevalence, and Clinical Characteristics of Patients with Chronic Lymphocytic Leukemia (CLL) in Spain: Natural Language Processing (NLP) Analysis of Electronic Health Records (EHRs)

    Dec 1, 2023, 00:00

  • HTA350 Fixed Effect Versus Random Effects Bayesian Network Meta-Analyses in Practi What Is Used to Inform National Institute for Health and Care Excellence (NICE) Technology Appraisals?

    Dec 1, 2023, 00:00

  • HTA269 Are We Leaving No One behind? Health Technology Assessment as a Pathway to Social Justice

    Dec 1, 2023, 00:00

  • EE98 Economic Burden of Patients with Paroxysmal Nocturnal Hemoglobinuria in China

    Dec 1, 2023, 00:00

  • EE493 Healthcare Resource Utilization Associated with Major Depressive Disorder with Insomnia Symptoms: A Retrospective Cohort Study in Hungary

    Dec 1, 2023, 00:00

  • EE293 Estimation of the Cost of the National Immunization Program for Children and Adolescents in Greece

    Dec 1, 2023, 00:00

  • EPH269 Estimating the Burden of Vaccine-Preventable Infectious Diseases Caused by Herpesviruses Beyond Herpes Zoster in Europe: What's Going on in Spain and Germany?

    Dec 1, 2023, 00:00

  • HPR153 Market Access Strategies for Advanced Therapy Drugs: A Comparative Analysis of the European and American Markets, Authorizations and Withdrawals

    Dec 1, 2023, 00:00

  • RWD75 An Innovative Data Collection System for Improving Outcomes in Patients Treated with Diabetes Technology

    Dec 1, 2023, 00:00

  • EPH91 The Incidence of Uveitis in the United Kingdom 2004-2021

    Dec 1, 2023, 00:00

  • HTA154 Trends of Indirect Treatment Comparison Methods Use in NICE Technology Appraisals for Haematologic Cancers

    Dec 1, 2023, 00:00

  • PCR161 Population Norms for the SF-36 Health Status Measure in Hungary

    Dec 1, 2023, 00:00

  • HPR127 Corporate Social Responsibility in Health Technology Industry, in Greece

    Dec 1, 2023, 00:00

  • EE365 Discrepancies Between Actual Costs and Reimbursement Tariffs for Breast Cancer Radiotherapy in Indonesia: A Hospital-Based Retrospective Study

    Dec 1, 2023, 00:00

  • HTA62 A Systematic Review of the New NICE Highly Specialised Technologies Criteria: How Do NICE Judge Criteria 3 and 4 to be Met?

    Dec 1, 2023, 00:00

  • MSR28 Examining Guidance and Key Principles for Conducting Living Systematic Reviews: A Methods Review

    Dec 1, 2023, 00:00

  • RWD23 Comparison of the Use of Real-World Evidence (RWE) by Health Technology Assessment (HTA) Agencies in Reviews of Drugs for Rare Diseases (DRDS)

    Dec 1, 2023, 00:00

  • EE719 Systematic Literature Review for Monetary Costs Data in Hemophilia

    Dec 1, 2023, 00:00

  • MSR109 Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment: Case-Study on Bevacizumab

    Dec 1, 2023, 00:00

  • MT30 Coverage and Payment Implications for Breakthrough Medical Devices Following Translational Coverage of Emerging Technologies (TCET) Proposed Rule in the US

    Dec 1, 2023, 00:00

  • EE669 Quality of Life and Economic Burden of Advanced Non-Small Cell Lung Cancer in Medium and Small Markets (MEDSM): A Systematic Literature Review

    Dec 1, 2023, 00:00

  • HPR29 Evolution of the Utilization of the Aifa 5% Fund for Orphan Drugs and Rare Diseases

    Dec 1, 2023, 00:00

  • EE95 Cost-Effectiveness Analysis of Pemigatinib for the Treatment of Adult Patients with Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement That Have Progressed After Systemic Therapy in Greece

    Dec 1, 2023, 00:00

  • HPR149 Generic Pricing Policy Frees Up $1 Billion: Statin Pricing and Expenditure from 2010-2022 in Australia.

    Dec 1, 2023, 00:00

  • HTA200 Review of Population-Adjusted Indirect Treatment Comparison Methods in NICE Non-Oncology Appraisals

    Dec 1, 2023, 00:00

  • EE336 Cost-Effectiveness Analysis of Isavuconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis in Jordan

    Dec 1, 2023, 00:00

  • Epidemiology Public Health

    Dec 1, 2023, 00:00

  • HTA16 Summary of Economic Evaluations on Onco-Hematology in France By the Has: What Did We Learn?

    Dec 1, 2023, 00:00

  • EE271 Cost-Effectiveness of Finerenone in Addition to Standard-of-Care in Treating Type 2 Diabetes and Chronic Kidney Disease in China

    Dec 1, 2023, 00:00

  • PCR22 Solidifying Usability Testing Guidelines for Ecoas From the Patient Perspective

    Dec 1, 2023, 00:00

  • HTA343 Machine Learning Prediction of Drug Overdoses Among Young People

    Dec 1, 2023, 00:00

  • EE540 Cost-Effectiveness of Brexucabtagene Autoleucel for the Treatment of Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in Patients Aged 26 Years or Older in the United Kingdom

    Dec 1, 2023, 00:00

  • HTA92 A Targeted Review of Methods for Effect Modifier (EM) and Prognostic Factor Identification in Population Adjusted Indirect Comparisons (PAICs) in NICE Oncology Submissions

    Dec 1, 2023, 00:00

  • MT45 Digital Health Applications in the General Practitioner Context of Care: An Empirical Analysis of Patient Acceptance

    Dec 1, 2023, 00:00

  • SA81 Has the Publication of China Guidelines for Pharmacoeconomic Evaluations 2020 influenced the Study Quality of Economic Evaluations in China? A Systematic Review

    Dec 1, 2023, 00:00

  • HPR10 Added Benefit and Revenues of Oncology Drugs Approved By the European Medicines Agency between 1995 and 2020

    Dec 1, 2023, 00:00

  • EPH137 Healthcare Resource Consumption and Direct Costs of Patients Newly Diagnosed with Acute Myeloid Leukemia from a Large Italian Administrative Database

    Dec 1, 2023, 00:00

  • RWD66 Characterization of the Variation of Opioid Prescription in 15 Dutch Hospitals: A Real World Data Analysis

    Dec 1, 2023, 00:00

  • EPH5 Prevalence and Predictive Factors of Severe Coronary Lesions in Algerian Patients Undergoing Coronary Angiography

    Dec 1, 2023, 00:00

  • RWD159 Comparison of Livingstone's Estimates of Prevalence of Six Different Rare Blood Cancers with Darwin EU

    Dec 1, 2023, 00:00

  • HSD63 New Pathway in Anti-HER2 Treatments’ Administration in Breast Cancer in Fran Which Impacts of the Involvement of an Advanced Practice Nurse in Hospital at Home Program?

    Dec 1, 2023, 00:00

  • MSR23 EQ-5D-5L Valuation Studies: Do the Effects of Dimensional Health Problems Interact with Each Other?

    Dec 1, 2023, 00:00

  • HTA109 A Review of the Use of Indirect Treatment Comparisons to Support Health Technology Assessments in Ireland

    Dec 1, 2023, 00:00

  • PCR248 Meaningful Within-Patient Change Threshold Range for the FACIT-Fatigue in Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Dec 1, 2023, 00:00

  • RWD158 Estimates on Waste of Breast Cancer Related Chemotherapy Drugs in the NHS (ENGLAND)

    Dec 1, 2023, 00:00

  • MSR54 COVID-19: Do All Patients Who Meet the EMA High-Risk Definition Receive Prescription?

    Dec 1, 2023, 00:00

  • PCR19 The EU Patient Community's Perspectives on Data Protection and Data Control

    Dec 1, 2023, 00:00

  • EE423 The Cost Savings Potential Associated with the Use of Nefecon for Adults with Primary IgA Nephropathy in the United States

    Dec 1, 2023, 00:00

  • HPR144 Support of RWE in the Price and Reimbursement Decision-Making Process for Rare Diseases in Spain

    Dec 1, 2023, 00:00

  • HSD53 Effect of COVID-19 Pandemic on the Delivery Time and the Point of Re-Order of Pharmaceuticals at the Logistics Services in a Governmental Hospital in Riyadh Saudi Arabia

    Dec 1, 2023, 00:00

  • HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece

    Dec 1, 2023, 00:00

  • PCR89 Predicting EQ-5D-5L Score by Using SGRQ in Patients with Asthma and/or COPD in NOVELTY

    Dec 1, 2023, 00:00

  • HTA257 Key HTA Learnings from Approved Gene Therapies Across the EU4, England, and the US

    Dec 1, 2023, 00:00

  • EE170 A Cost-Effectiveness Analysis, with Public Healthcare Payers’ Perspective, of Oral Semaglutide Versus Luseogliflozin Hydrate for Patients with Type 2 Diabetes Mellitus in a Japanese Clinical Setting

    Dec 1, 2023, 00:00

  • CO19 Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

    Dec 1, 2023, 00:00

  • EE447 Working With Probabilistic Models for Cost-Effectiveness Analysis: Computational Tools Integrating Exact Methods vs Simulation-Based Approaches

    Dec 1, 2023, 00:00

  • PCR206 Characterization of the Lupus Patient Experience Based on Longitudinal Patient Generated Real World Data from a Digital Health App (HEALTH STORYLINES)

    Dec 1, 2023, 00:00

  • HSD127 Impact of the COVID-19 Pandemic on Frequency of Surgeries in Germany Based on Hospital Data

    Dec 1, 2023, 00:00

  • EE5 The Health Return on Investment (ROI) Assessor: Evaluating Novel Cardiovascular Disease (CVD) Prevention Approaches in Estonia

    Dec 1, 2023, 00:00

  • HTA332 Evaluating Transcatheter Valve Replacement in Tricuspid Regurgitation: Complexities and Limitations of Existing Models

    Dec 1, 2023, 00:00

  • HTA340 Is There Equity of Access to Highly Specialized Treatments Between England and Northern Ireland?

    Dec 1, 2023, 00:00

  • EPH153 Clinical Characterization and Healthcare Resource Utilization in Adrenoleukodystrophy: A Nationwide Retrospective Cohort Using Swedish National Registries

    Dec 1, 2023, 00:00

  • SA11 A Systematic Review on the Safety and Effectiveness of the Active Middle Ear Implant in the Treatment of Conductive and Mixed Hearing Loss

    Dec 1, 2023, 00:00

  • HTA70 The Italian Healthcare System Competences in View of the New European HTA Regulation

    Dec 1, 2023, 00:00

  • EE167 Budget Impact Analysis of Sensor Augmented Pump Therapy for Type 1 Diabetes (T1D) in Bulgaria

    Dec 1, 2023, 00:00

  • EE13 Using Sensor-Based Glucose Monitors Dominates Self-Monitoring of Blood Glucose for Adults with Type 1 Diabetes in the Danish Healthcare Setting

    Dec 1, 2023, 00:00

  • HTA78 Examining the Influence of Study Design, Incremental Medical Benefit, and Price-Setting Pathway on Pricing of Digital Health Applications in Germany

    Dec 1, 2023, 00:00

  • HPR43 Are There Any Common Denominators for Early Access Programs in Europe?

    Dec 1, 2023, 00:00

  • The Impact of Cost-Containment Initiatives from across the Globe

    Dec 1, 2023, 00:00

  • MSR151 Causal Machine Learning for Assessing Pneumococcal Vaccine Effectiveness: Innovations in Real-World Data Analysis and Confounding Pathway Adjustment

    Dec 1, 2023, 00:00

  • Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report

    Dec 1, 2023, 00:00

  • HSD56 Utilization of Vascular Assessment Before Lower Extremity Amputation Among Patients With Diabetic Foot Ulcerations in the US

    Dec 1, 2023, 00:00

  • EE638 Cost-Effectiveness of Vasopressin Alone or in Combination With SOC in the Treatment of Sepsis and Septic Shock Patients

    Dec 1, 2023, 00:00

  • EE427 Health Economic Decision Models Used in the Cost-Effectiveness Analyses of Innovative Products Submitted to the French National Authority for Health (HAS)

    Dec 1, 2023, 00:00

  • HTA231 What Is the Psycho-Oncologic (PsyO) Impact of Progression in Patients with Cancer? A Targeted Literature Review (TLR) to Assess the Available Data

    Dec 1, 2023, 00:00

  • RWD134 Assessing the Association between Pain Burden and Limitations Among Older United States Adults with Pain who Used Opioids

    Dec 1, 2023, 00:00

  • EE476 Cost Analysis of Patiromer Versus Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in the UK, Italy and Spain

    Dec 1, 2023, 00:00

  • EPH49 The Short-Run and Long-Run Behavioral Effects of Vaccination Enforcement in Turkey

    Dec 1, 2023, 00:00

  • RWD63 Clinical Outcomes in Non-Inhibitor Severe Haemophilia A Patients Receiving Prophylaxis Across Currently Available Haemophilia A Treatments: Insights Form the ‘Cost of Haemophilia: A Socioeconomic Survey III’ (CHESS III) Study

    Dec 1, 2023, 00:00

  • HSD52 Employess Satisfaction Level from Working Conditions at the Public Psychiatric Hospital of Athens, Greece

    Dec 1, 2023, 00:00

  • EE466 Economic Evaluation of Improving Medication Adherences for Secondary Cardiovascular Disease Prevention: A Threshold Analysis

    Dec 1, 2023, 00:00

  • CO153 Exploring the Impact of Healthcare Provider Stress on Patient Outcomes: A Review Protocol

    Dec 1, 2023, 00:00

  • SA82 Systematic Versus Rapid Review: The Impact of Database Coverage and Single Studies Selection on the Review's Conclusions

    Dec 1, 2023, 00:00

  • HTA130 Different Approaches to the Health Economic Evaluations for the Health Technology Assessment Submissions

    Dec 1, 2023, 00:00

  • HPR130 Analysis of Extemporaneous Compounding of Medicines During COVID-19 and Wartime in Ukraine

    Dec 1, 2023, 00:00

  • HTA17 Comparison of Methods for Modelling the Cost-Effectiveness of Atezolizumab as an Adjuvant Treatment in Stage II-IIIA Non-Small Cell Lung Cancer

    Dec 1, 2023, 00:00

  • HTA216 Analyzing Delays in Economic Appraisal in France : A Comparative Study of 2021 and 2022

    Dec 1, 2023, 00:00

  • RWD162 Evolution of Breast Cancer Treatment Cost in the Last 36 Months: An Analysis From a Health Payer Perspective in Brazil

    Dec 1, 2023, 00:00

  • EPH139 A Retrospective Cohort Study of Pediatric Patients Undergoing Percutaneous Vascular Procedures

    Dec 1, 2023, 00:00

  • EE708 Cost-Effectiveness of Umeclidinium/Vilanterol (UMEC/VI) Versus Aclidinium/Formoterol (ACL/FOR) in Patients with COPD in the United Kingdom

    Dec 1, 2023, 00:00

  • PCR238 Measuring the Socioeconomic Impact of Cancer: A Systematic Review and Quality Appraisal of Patient-Reported Outcome (PRO) Instruments

    Dec 1, 2023, 00:00

  • PCR97 Impact of Paroxysmal Nocturnal Haemoglobinuria on Employment and Activity: Results from a Real-World Study

    Dec 1, 2023, 00:00

  • HTA155 The Impact of Phase 2 Clinical Trials on Reimbursement Recommendations in Oncology By Canadian Health Technology Assessment Agencies

    Dec 1, 2023, 00:00

  • HTA120 Trends in Medical Device Reimbursement Decisions in South Korea: A Novel and Comprehensive Analysis

    Dec 1, 2023, 00:00

  • PCR120 A Psychometric Evaluation of the RAND 36 Scale Among Japanese Adults With Insomnia in 2023

    Dec 1, 2023, 00:00

  • EE575 Economic Analysis of the Costs Associated With Reusable Flexible Ureteroscopes – Implications for the Utilization of Single-Use Digital Flexible Ureteroscopes

    Dec 1, 2023, 00:00

  • MSR143 Extending Bayesian Evidence Synthesis to Include Historical Trial Data for Improved Survival Extrapolations from Early Data Cuts in Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Dec 1, 2023, 00:00

  • Adherence to Treatment, Patients' Preferences, and Drug Use across Multiple Diseases

    Dec 1, 2023, 00:00

  • EE44 Health Care Resource Utilization and Cost in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada

    Dec 1, 2023, 00:00

  • EE531 Resource Optimization for Greek NHS Hospitals from the Use of Daratumumab SC for Multiple Myeloma

    Dec 1, 2023, 00:00

  • CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?

    Dec 1, 2023, 00:00

  • HPR151 New Proposed European Commission Pharmaceutical Regulation – Potential Changes and Impact on Biosimilars

    Dec 1, 2023, 00:00

  • CO34 Mortality and Clinical Complications Among Patients with Transfusion-Dependent Beta-Thalassemia in France

    Dec 1, 2023, 00:00

  • MT16 A Review of NICE Submissions for Medical Technologies in the UK: Key Trends over the Last 2 Years

    Dec 1, 2023, 00:00

  • PCR205 Determination of Ranges of HSSDD HSSQ Scores Defining Clinically Meaningful Within-Patient Improvement Thresholds and Severity Levels

    Dec 1, 2023, 00:00

  • HPR87 A Comparative Analysis of Market Access Processes Between Ukraine and Germany

    Dec 1, 2023, 00:00

  • EE557 Economic Burden of Cystic Fibrosis in Five Key European Countries: A Systematic Review

    Dec 1, 2023, 00:00

  • HSD23 Health Technology Management - The Future of the Post-Reimbursement Phase?

    Dec 1, 2023, 00:00

  • EE468 The Full Circle: Systematic Evaluation, Replication and Validation of Structural Health Economic Modelling Approaches: Lessons Learned in the Field of Obesity

    Dec 1, 2023, 00:00

  • EE723 Budget Impact of New Potassium-Lowering Therapies in the Treatment of Chronic Hyperkalemia: A Saudi Experience

    Dec 1, 2023, 00:00

  • MSR138 On When and How to Use External Data to Inform Long-Term Survival Curve Extrapolation

    Dec 1, 2023, 00:00

  • MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias

    Dec 1, 2023, 00:00

  • EE164 Cost-Effectiveness of Inclisiran as Add-on Therapy to Standard-of-Care for the Secondary Prevention of Cardiovascular Events in Patients with Elevated LDL Cholesterol

    Dec 1, 2023, 00:00

  • MT7 Barriers and Facilitators for the Use of Point of Care Diagnostics in Patients With Respiratory Tract Infections in Outpatient Care Related to the Peri-Launch Phase

    Dec 1, 2023, 00:00

  • PCR186 Patient Engagement in Real-World Data Collection: User Characteristics of a Health App for People Living With Pancreatic Cancer

    Dec 1, 2023, 00:00

  • EPH73 Modelling the Wider Socio-Economic Costs of Problematic Opioid Use in Germany

    Dec 1, 2023, 00:00

  • PCR175 Real-World Impact of Migraine on Canadians’ Productivity: A Pharmacy-Based Study

    Dec 1, 2023, 00:00

  • RWD13 Treatment Pathways and Outcomes of Advanced Ovarian Cancer Patients Who Are Underrepresented in Trials

    Dec 1, 2023, 00:00

  • EE647 Excess Healthcare Resource Use Among Subgroups With Anxiety and Depressive Symptoms in Hungary

    Dec 1, 2023, 00:00

  • EE370 Cost-Effectiveness Analysis of Pembrolizumab as Adjuvant Treatment for Resected Stage IIB/IIC Melanoma in Greece

    Dec 1, 2023, 00:00

  • PT24 Reimbursement Decisions in Ireland; Utilising Text Mining to Assess Factors Contributing to Decision Making

    Dec 1, 2023, 00:00

  • HTA226 Can Prior Indirect Treatment Comparisons (ITCs) Inform Health Technology Assessment (HTA) Strategy: A Case Study in Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL)

    Dec 1, 2023, 00:00

  • HSD40 Fecal Incontinence of Patients After Stoma Reversal: A German Claims Data Analysis Reveals Concerns

    Dec 1, 2023, 00:00

  • PCR69 Understanding Determinants of the Burden Experienced by Informal Caregivers of Myasthenia Gravis Patients

    Dec 1, 2023, 00:00

  • PCR27 Association between Health-Related Quality of Life and Requirement for Non-Professional Care in Adults with Rare Diseases: A Real-World Study

    Dec 1, 2023, 00:00

  • EE15 Cost-Effectiveness Analysis of Oral Semaglutide as the Second-Line and Third-Line Treatment for Type 2 Diabetes Patient

    Dec 1, 2023, 00:00

  • CO35 Clinical Outcomes Associated with Sodium Zirconium Cyclosilicate for Treating Hyperkalaemia in Patients Receiving Haemodialysis

    Dec 1, 2023, 00:00

  • PCR243 Psychometric Validation of QlQ-OES18 in 2L Esophageal Squamous Cell Cancer (ESCC) Patients Treated with Tislelizumab Versus Chemotherapy

    Dec 1, 2023, 00:00

  • OP5 Multistakeholder Healthcare Cooperative: A New Paradigm for Healthcare Delivery

    Dec 1, 2023, 00:00

  • EE133 Potential Budget Impact of Negative Pressure Wound Therapy (NPWT) Versus Conventional Wound Treatment (CWT) in Diabetic Foot Ulcers (DFU), Surgical Abdominal Wounds with Healing Impairment (SAWHI), and Trauma Wounds for Mexico

    Dec 1, 2023, 00:00

  • HTA206 How Do the Stricter Pricing Regulations of the Statutory Health Insurance Financial Stabilization Act (GKV-FINSTG) Affect Reimbursement Prices of New Drugs in Germany?

    Dec 1, 2023, 00:00

  • RWD153 Economic and Humanistic Burden Among Patients With Non-Radiographic Axial Spondyloarthritis in China

    Dec 1, 2023, 00:00

  • HTA303 Are BSC and Patient-Individual Therapy as Appropriate Comparators Detrimental for AMNOG Benefit Assessment and Price Rebates in Germany?

    Dec 1, 2023, 00:00

  • SA43 Methods of Estimating Annualized Bleed Rates from Medical Records Among Patients with Hemophilia A

    Dec 1, 2023, 00:00

  • EE482 Economic Cost of Implementation of a Frailty Care Bundle to Reduce Risk of Hospital Associated Decline Among Older Patients

    Dec 1, 2023, 00:00

  • MSR145 Identifying Effect of a Treatment from Observational Data in Absence of Contemporaneous Control: Example of the French Study Tosca, Comparing Cemiplimab Vs. Historical Systemic Treatment in Cutaneous Squamous Cell Carcinoma

    Dec 1, 2023, 00:00

  • EPH38 Exploring the Relationship Between Hemochromatosis and Fracture Risk: A Population-Based Matched Cohort Study Stratified on Ferritin Levels

    Dec 1, 2023, 00:00

  • PCR264 Impact of Sodium Glucose Cotransporter-2 Inhibitors (SGLT2is) on Health-Related Quality of Life (HRQoL) Outcomes in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

    Dec 1, 2023, 00:00

  • EE214 The Cost-Effectiveness of Abemaciclib Combined With Endocrine Therapy (ET) for the Treatment of Persons With HR+, HER2- Node Positive, Early Breast Cancer (EBC) at High Risk of Recurren A Spanish Healthcare Perspective

    Dec 1, 2023, 00:00

  • HPR2 Baseline Characteristics of Patients Applying for Reimbursment of Liraglutide (Saxenda®) for Weight Management Under a Managed Access Protocol in Ireland

    Dec 1, 2023, 00:00

  • PCR265 A Core Outcome Set for the Evaluation of New Healthcare Programs in Sweden

    Dec 1, 2023, 00:00

  • PCR269 Detecting Changes in Relative Weighting of EQ-5D Dimensions and Levels with Sequential Analytical Hierarchy Process in Hong Kong Sar, China

    Dec 1, 2023, 00:00

  • SA22 Tepotinib Versus Chemotherapy in Met Exon 14 (METex14) Skipping Non-Small Cell Lung Cancer (NSCLC): Real-World Evidence (RWE) and Matching-Adjusted Indirect Comparison (MAIC) to Explore the Impact of Subsequent Therapy

    Dec 1, 2023, 00:00

  • EE17 Societal Burden of Non-Alcoholic Steatohepatitis (NASH) in Denmark - Real-World Evidence from National Registries

    Dec 1, 2023, 00:00

  • MT31 The Promising Future of Digital Health: A Road to Reimbursement in US EU5 Markets?

    Dec 1, 2023, 00:00

  • HPR98 Examining Reimbursement and Pricing Decisions of Oncohematological Medicines in Spain

    Dec 1, 2023, 00:00

  • HTA36 Monitoring of the Long-Term Impact of the COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency

    Dec 1, 2023, 00:00

  • EE454 What Is the Goal of Value-Based Pricing, and to Whom Is Value Created?

    Dec 1, 2023, 00:00

  • PCR256 Correlation of Patient-Reported Vitiligo Noticeability Scale With Physician-Assessed Facial Vitiligo Area Scoring Index Responses: Post Hoc Analyses From the True-V Trials of Ruxolitinib Cream in Vitiligo

    Dec 1, 2023, 00:00

  • PCR90 Hypoglossal Nerve Stimulation (HGNS) for Obstructive Sleep Apnea (OSA): A Systematic Review and Meta-Analysis of Patient-Reported Outcomes

    Dec 1, 2023, 00:00

  • PCR43 A Review of Migraine-Related Pros in FDA Labelling Claims (2018-2023)

    Dec 1, 2023, 00:00

  • EE55 Cost-Effectiveness of ESMO-Recommended Lenvatinib and Pembrolizumab Regimen as Second-Line Treatment for Advanced Endometrial Carcinoma in Taiwan: A Comparison With NCCN Recommendations

    Dec 1, 2023, 00:00

  • P51 Testing a Survival Extrapolation Algorithm for Cancer Immunotherapies: Pass or Fail?

    Dec 1, 2023, 00:00

  • CO97 Real-World Outcomes in Third-Line and Beyond (3L+) Small-Cell Lung Cancer (SCLC): A Systematic Literature Review (SLR)

    Dec 1, 2023, 00:00

  • MSR13 Formulating Bayesian Poly-Hazard Models for Informed and Clinically Interpretable Lifetime Survival Extrapolations in Advanced Non-Small Cell Lung Cancer (aNSCLC)

    Dec 1, 2023, 00:00

  • CO104 Identification and Selection of Biomarkers in Patient-Centric Treatment Management of Rare/Orphan Kidney Diseases: An Ongoing Research Project Aiming to Develop Personalized Treatment Algorithms

    Dec 1, 2023, 00:00

  • HTA183 Setting the Right Discount Rate for Health Technology Assessment in the Slovak Republic

    Dec 1, 2023, 00:00

  • EE597 Data on Human Population Mobility in Individual-Based Models of Infectious Disease Transmission: A Systematic Review

    Dec 1, 2023, 00:00

  • EE201 Clinical and Economic Consequences of Epilepsy Treatment across Incremental Treatment Lines in Spain: A Real Life Database Analysis

    Dec 1, 2023, 00:00

  • EE45 Differing Approaches to the Health Economic Investigation of the Informal Care of People Living With Multiple Sclerosis: A Systematic Review and Meta-Analysis

    Dec 1, 2023, 00:00

  • EE716 Resource Utilisation and Healthcare Costs Among Patients with Age-Related Macular Degeneration (NAMD) in Italy: Findings from the Radiance Observational Substudy

    Dec 1, 2023, 00:00

  • MSR94 Harnessing AI in Health Economics: Enhancing Efficiency, Accuracy, and Decision-Making

    Dec 1, 2023, 00:00

  • EE694 Evaluation of Healthcare Resource Utilization and Cost Among First-Line Patients Receiving Ibrutinib Vs Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Commercial Claims Database Analysis

    Dec 1, 2023, 00:00
  • «
  • 11
  • 12
  • 13 (current)
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »